Trump Declines to Participate in House Impeachment Hearing
(Bloomberg) -- President Donald Trump's lawyer on Sunday told the House Judiciary Committee the White House would not take part in the panel's first impeachment hearing on Wednesday, but kept open the possibility he would be represented at future sessions.
Pat Cipollone, counsel to the president, rejected the invitation to take part, criticizing the panel for demanding a response before any witnesses have been named or a schedule for other hearings has been set. He said the entire process has been unfair to the president.
“We cannot fairly be expected to participate in a hearing while the witnesses are yet to be named and while it remains unclear whether the Judiciary Committee will afford the president a fair process through additional hearings,” Cipollone wrote to Judiciary Committee Chairman Jerrold Nadler of New York.
He also said the hearing was scheduled -- “no doubt purposely” -- while Trump is out of the country at a NATO leaders' meeting in London.
The Wednesday hearing will examine whether Trump's actions as detailed in the evidence gathered so far warrant articles of impeachment. The panel also plans to explain the constitutional framework for impeachment and the term “high crimes and misdemeanors.” The committee had received the letter Sunday night, but issued no immediate comment.
Read more: House Invites Trump to Dec. 4 Hearing
Trump has repeatedly assailed the impeachment proceedings, led by Democrats, calling it a “witch hunt” that seeks to overturn the results of the 2016 election. The president routinely says he did nothing wrong in his effort to press Ukraine's president, Volodymyr Zelenskiy, to open investigations that could be damaging to his political rivals, including former Vice President Joe Biden.
Nadler gave Trump a deadline of 6 p.m. Sunday to say whether he or his attorney plans to participate in the hearing. In a Nov. 26 letter to Trump, Nadler said the president's counsel can make a request to question a panel of as yet unnamed witnesses who will discuss the constitutional basis for impeachment.
“An invitation to an academic discussion with law professors does not begin to provide the president with any semblance of a fair process. Accordingly, under the current circumstances, we do not intend to participate in your Wednesday hearing,” Cipollone wrote.
“Nevertheless, if you are serious about conducting a fair process going forward, and in order to protect the rights and privileges of the president, we may consider participating in future Judiciary Committee proceedings if you afford the Administration the ability to do so meaningfully,” he said.
Cipollone left open whether Trump and his lawyers will participate in any Judiciary Committee hearings on impeachment, saying they will respond to that issue separately.
He wrote the White House first wants answers to whether Nadler will allow the president and his lawyer, as well as committee Republicans, to call witnesses, including those Republicans sought to call but were blocked during Intelligence Committee hearings led by Democrat Adam Schiff. They also want to know whether Nadler will let Republican committee members and the president's lawyers the right to cross examine witnesses.
Senate's 2020 Hopefuls Map Out How to Navigate Impeachment Trial
Democrats to Accuse Trump of Seeking Foreign Election Help
Trump Renews Attacks on Yovanovitch, Other House Witnesses
To contact the reporter on this story: Billy House in Washington at bhouse5@bloomberg.net
To contact the editors responsible for this story: Joe Sobczyk at jsobczyk@bloomberg.net, Steve Geimann, Linus Chua
©2019 Bloomberg L.P.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.